@misc{10481/70244,
year = {2021},
month = {5},
url = {http://hdl.handle.net/10481/70244},
abstract = {Background: Psoriasis is a chronic inflammatory disease that has a negative impact on patients’ quality
of life. Patients with mild–moderate psoriasis can be treated with topical medications, such as the
combination drug calcipotriol/betamethasone dipropionate (Cal/BD).
Objectives: This study investigated the adherence of psoriasis patients to therapy with Cal/BD aerosol
foam, as well as their satisfaction with the treatment’s efficacy, safety, and effect on their quality of life.
Methods: Patients with mild–moderate plaque psoriasis were eligible to participate in this open-label,
non-placebo controlled, prospective single-center study. Adherence to treatment was assessed using the
Morisky-Green scale 4 and 12 weeks after the start of treatment. Satisfaction with the treatment was
assessed using the abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9). The
severity of psoriasis was assessed on the mIGA and PGA scales, and the impact on quality of life was
assessed using the PDI and DLQI scales.
Results: A total of 65 patients entered the study. Adherence to treatment was good, with 73.8% of
patients showing high adherence at 12 weeks. Satisfaction was also good, with 46 patients (70.8%)
being completely satisfied. Conclusions: Over a 4-week period, patients treated with Cal/BD aerosol foam had significant improvement
in disease severity that was directly related to treatment adherence.},
organization = {LEO Pharma},
publisher = {Derm101},
keywords = {Adherence},
keywords = {Satisfaction},
keywords = {Calcipotriol/betamethasone},
keywords = {Aerosol foam},
keywords = {Psoriasis},
title = {Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use},
doi = {10.5826/dpc.1103a56},
author = {Navarro Triviño, Francisco José and Lozano Lozano, Mario and Ruiz Villaverde, Ricardo},
}